[go: up one dir, main page]

DE69731106D1 - Neue pikcornaviren, impfstoffe und diagnostische kits - Google Patents

Neue pikcornaviren, impfstoffe und diagnostische kits

Info

Publication number
DE69731106D1
DE69731106D1 DE69731106T DE69731106T DE69731106D1 DE 69731106 D1 DE69731106 D1 DE 69731106D1 DE 69731106 T DE69731106 T DE 69731106T DE 69731106 T DE69731106 T DE 69731106T DE 69731106 D1 DE69731106 D1 DE 69731106D1
Authority
DE
Germany
Prior art keywords
picornaviruses
protein
seq
diagnostic kits
syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69731106T
Other languages
English (en)
Other versions
DE69731106T2 (de
Inventor
Bo Niklasson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
APODEMUS KALMAR AB
Original Assignee
APODEMUS KALMAR AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by APODEMUS KALMAR AB filed Critical APODEMUS KALMAR AB
Publication of DE69731106D1 publication Critical patent/DE69731106D1/de
Application granted granted Critical
Publication of DE69731106T2 publication Critical patent/DE69731106T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
DE69731106T 1996-09-11 1997-09-09 Neue pikcornaviren, impfstoffe und diagnostische kits Expired - Lifetime DE69731106T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9603305A SE9603305D0 (sv) 1996-09-11 1996-09-11 New picornaviruses, vaccines and diagnostic kits
SE9603305 1996-09-11
PCT/SE1997/001515 WO1998011133A1 (en) 1996-09-11 1997-09-09 New picornaviruses, vaccines and diagnostic kits

Publications (2)

Publication Number Publication Date
DE69731106D1 true DE69731106D1 (de) 2004-11-11
DE69731106T2 DE69731106T2 (de) 2006-02-23

Family

ID=20403847

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69731106T Expired - Lifetime DE69731106T2 (de) 1996-09-11 1997-09-09 Neue pikcornaviren, impfstoffe und diagnostische kits

Country Status (10)

Country Link
US (3) US7101554B2 (de)
EP (1) EP0941240B1 (de)
JP (1) JP4440345B2 (de)
AT (1) ATE278709T1 (de)
AU (1) AU4143597A (de)
DE (1) DE69731106T2 (de)
EA (1) EA199900286A1 (de)
ES (1) ES2229386T3 (de)
SE (1) SE9603305D0 (de)
WO (1) WO1998011133A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603305D0 (sv) * 1996-09-11 1996-09-11 Bo Niklasson New picornaviruses, vaccines and diagnostic kits
GB0120437D0 (en) * 2001-08-22 2001-10-17 Nya Apodemus Ab Diabetic model
AU2003228072A1 (en) * 2002-04-23 2003-11-10 Susanne Johansson A new family of picornaviruses
DE602004014728D1 (de) 2003-02-21 2008-08-14 Apodemus Ab Behandlung von durch das ljungan-virus ausgelösten erkrankungen durch verwendung von pleconaril
AU2006343645B2 (en) * 2006-05-01 2011-12-22 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Methods and agents for detecting Parechovirus
US8326439B2 (en) * 2008-04-16 2012-12-04 Nevro Corporation Treatment devices with delivery-activated inflatable members, and associated systems and methods for treating the spinal cord and other tissues
WO2011041788A2 (en) * 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Turkey viral hepatitis virus and uses thereof
US9572528B1 (en) 2012-08-06 2017-02-21 Los Angeles Biomedical Research Insitute at Harbor-UCLA Medical Center Monitor for SIDS research and prevention

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229111A (en) * 1991-01-31 1993-07-20 Wiscosnin Alumni Research Foundation Method of inhibiting picornavirus disease
SE9603305D0 (sv) * 1996-09-11 1996-09-11 Bo Niklasson New picornaviruses, vaccines and diagnostic kits

Also Published As

Publication number Publication date
JP4440345B2 (ja) 2010-03-24
US20070003574A1 (en) 2007-01-04
SE9603305D0 (sv) 1996-09-11
ATE278709T1 (de) 2004-10-15
EP0941240B1 (de) 2004-10-06
AU4143597A (en) 1998-04-02
US7855277B2 (en) 2010-12-21
US7101554B2 (en) 2006-09-05
JP2001500503A (ja) 2001-01-16
EA199900286A1 (ru) 2000-04-24
DE69731106T2 (de) 2006-02-23
EP0941240A1 (de) 1999-09-15
US20070003573A1 (en) 2007-01-04
ES2229386T3 (es) 2005-04-16
WO1998011133A1 (en) 1998-03-19
US20030044960A1 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
Lu et al. A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike
Webby et al. Protection and compensation in the influenza virus-specific CD8+ T cell response
US6811780B2 (en) Methods of using cytokine antagonists to treat HIV infection and AIDS
JP5642672B2 (ja) 弱毒化ペスチウイルス
US7371525B2 (en) Compositions and methods for diagnosing and treating severe acute respiratory syndrome (SARS)
RU2012102339A (ru) Полипептиды из neisseria meningitidis
WO2001062287A1 (en) Methods of prevention and treatment of asthma, and allergic conditions
JPH09501165A (ja) Ｂ型肝炎ウイルスに対する細胞毒性ｔリンパ球応答を誘発するためのペプチド
EP2201035A1 (de) Neue vogel-zytokine und für diese codierende genetische sequenzen
DE69731106D1 (de) Neue pikcornaviren, impfstoffe und diagnostische kits
KR20010030620A (ko) 호흡 신시티아 바이러스의 부착 (지) 단백질에서 유도된펩티드
US5622861A (en) Recombinant DNA encoding hepatitis A virus receptor
EP1797112B1 (de) Inhibitoren des hepatitis-c-virus
US20040005321A1 (en) Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotheraphy
de Wit et al. Host-dependent type 1 cytokine responses driven by inactivated viruses may fail to default in the absence of il-12 or ifn-α/β
US20230079898A1 (en) Compositions and methods for treating and preventing hepatitis b and d
Weiss et al. Pathogenesis of murine coronavirus infection
Zonaro et al. Differential pattern of sequence heterogeneity in the hepatitis C virus E1 and E2/NS1 proteins
KR102797156B1 (ko) 사스 코로나바이러스 2 베타 변이주 항원 및 이를 포함하는 고효능 백신 조성물
US20060269562A1 (en) Polypeptides f' of the hepatitis c virus, t epitopeo, and the diagnostic and therapeutic applications thereof
Minami et al. A NOVEL SENSITIVE METHOD FOR THE DETECTION OF LAMIVU-DINE-RESISTANT HBV MUTANTS USING PEPTIDE NUCLEIC ACIDS-MEDIATED PCR CLAMPING AND RESTRICTION FRAGMENT LENGTH
KR20240124455A (ko) 신규한 저온-적응성 약독화 중동호흡기증후군 코로나바이러스
CN104780918A (zh) 用于预防和/或治疗丙型肝炎的氮杂环丁酮化合物及其组合物
Greeneltch Modulation of inflammatory and T helper cell responses by opioids and IL-4: Direct effects on cytokine production, death effector expression, and activation-induced cell death
Kim et al. Analysis of the envelope region of hepatitis G virus isolated from Korean patients

Legal Events

Date Code Title Description
8364 No opposition during term of opposition